Summary Basis for Regulatory Action Template

First Page		Document Content
Microbiology Pneumococcal vaccine Pneumococcal polysaccharide vaccine Zostavax Merck & Co. Immunogenicity Varicella zoster virus Streptococcus pneumoniae Vaccines Medicine Biology		Summary Basis for Regulatory Action Template Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 66,01 KB Share Document on Facebook

	Trabajos Libres 2017 MENINGITIS POR STREPTOCOCCUS PNEUMONIAE EN LA ERA DE LA VACUNACION Título: ANTINEUMOCICCICA: REPORTE DE CASO Autor: PANDURO VALDEZ LI Co-autor: BECERRA TREJO BG; ESPINOZA OLIVA MM DocID: 1vmc2 - View Document
	Ministerio de Salud BOLETÍN VIGILANCIA DE LABORATORIO Vigilancia de Laboratorio de Streptococcus pneumoniae DocID: 1uREL - View Document
	1 Vol. 4, No. 11, NoviembreVigilancia de Enfermedad Invasora Streptococcus pneumoniae. Chile, 2007 – 2014. DocID: 1uDbc - View Document
	Ministerio de Salud VIGILANCIA DE LABORATORIO Comportamiento de Streptococcus pneumoniae serotipos 3 y 19 A en DocID: 1udYJ - View Document
	LASCCO Announces Positive Scientific Advice Meeting with MHRA and Plans a First-In-Man Clinical Trial with CAL02 in Patients with Severe Pneumococcal Pneumonia GENEVA, SWITZERLAND, 22 October 2014 – LASCCO SA has held DocID: 1rhtI - View Document